These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3396493)

  • 1. Pharmacokinetics of cefotaxime and desacetylcefotaxime in renal failure patients undergoing continuous arteriovenous haemofiltration.
    Hasegawa H; Takahashi K; Imada A; Horiuchi A
    Drugs; 1988; 35 Suppl 2():78-81. PubMed ID: 3396493
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacokinetics of cefmenoxime in renal-failure patients undergoing continuous arteriovenous hemofiltration].
    Hasegawa H; Itagaki N; Tsujino M; Takahashi K; Yamamoto Y; Imada A; Horiuchi A
    Jpn J Antibiot; 1988 Mar; 41(3):338-41. PubMed ID: 3165473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of ranitidine in patients undergoing haemofiltration.
    Gladziwa U; Krishna DR; Klotz U; Ittel TH; Schunkert H; Glöckner WM; Mann H
    Eur J Clin Pharmacol; 1988; 35(4):427-30. PubMed ID: 3197752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival in patients treated with continuous arteriovenous hemodialysis for acute renal failure and chronic renal failure. Preliminary observations.
    Geronemus RP; Schneider NS; Epstein M
    Contrib Nephrol; 1991; 93():29-31. PubMed ID: 1802596
    [No Abstract]   [Full Text] [Related]  

  • 5. Influence of gender on the disposition of cefotaxime and desacetylcefotaxime.
    Guay DR; Matzke GR; Heim KL; Halstenson CE; Abraham PA; Keane WF
    Ther Drug Monit; 1987 Sep; 9(3):259-62. PubMed ID: 3672567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of continuous arteriovenous haemofiltration and haemodialysis in acute renal failure.
    Maher ER; Hart L; Levy D; Scoble JE; Baillod RA; Sweny P; Varghese Z; Moorhead JF
    Lancet; 1988 Jan; 1(8577):129. PubMed ID: 2891977
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of continuous arteriovenous haemofiltration on pharmacokinetics of amrinone.
    Lawless S; Restaino I; Azin S; Corddry D
    Clin Pharmacokinet; 1993 Jul; 25(1):80-2. PubMed ID: 8354019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience of pumped arteriovenous haemofiltration in the management of patients in oliguric renal failure following cardiothoracic surgery.
    Morgan JM; Morgan C; Evans TW
    Int J Cardiol; 1988 Dec; 21(3):259-67. PubMed ID: 3229864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of cefotaxime and desacetylcefotaxime in elderly patients.
    Ludwig E; Székely E; Csiba A; Graber H
    Drugs; 1988; 35 Suppl 2():51-6. PubMed ID: 3396489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure.
    Davenport A; Will EJ; Losowsky MS; Swindells S
    Br Med J (Clin Res Ed); 1987 Oct; 295(6605):1028. PubMed ID: 3120861
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of continuous haemofiltration to assess the rate of lactate metabolism in acute renal failure.
    Wright DA; Forni LG; Carr P; Treacher DF; Hilton PJ
    Clin Sci (Lond); 1996 Jun; 90(6):507-10. PubMed ID: 8697721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of continuous arteriovenous hemofiltration and continuous arteriovenous dialysis in critically ill patients.
    Raja R; Kramer M; Goldstein S; Caruana R; Lerner A
    ASAIO Trans; 1986; 32(1):435-6. PubMed ID: 3535850
    [No Abstract]   [Full Text] [Related]  

  • 13. [Continuous hemofiltration in the treatment of acute kidney failure in multiple organ failure].
    Robert R; Rouffineau J; Descoins P; Malin F; Antoun S; Carretier M
    Presse Med; 1990 Oct; 19(35):1615-8. PubMed ID: 2147253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cefotaxime in dialysis patients.
    Andrassy K
    Diagn Microbiol Infect Dis; 1995; 22(1-2):85-7. PubMed ID: 7587055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemodynamic consequences of continuous arteriovenous hemofiltration.
    Lauer A; Alvis R; Avram M
    Am J Kidney Dis; 1988 Aug; 12(2):110-5. PubMed ID: 3400631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the pharmacokinetics of various beta-lactams after intravenous and intraperitoneal administration in patients undergoing continuous ambulatory peritoneal dialysis.
    Imada A; Itagaki N; Hasegawa H; Horiuchi A
    Drugs; 1988; 35 Suppl 2():82-7. PubMed ID: 3165065
    [No Abstract]   [Full Text] [Related]  

  • 17. Is continuous haemofiltration superior to intermittent dialysis and haemofiltration treatment?
    Sieberth HG; Kierdorf H
    Adv Exp Med Biol; 1989; 260():181-92. PubMed ID: 2696367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefotaxime and metabolite disposition in two pediatric continuous ambulatory peritoneal dialysis patients.
    Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JA
    Ann Pharmacother; 1992 Mar; 26(3):341-3. PubMed ID: 1554953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypochloraemic alkalosis after high-flux continuous haemofiltration and continuous arteriovenous haemofiltration with dialysis.
    Davenport A; Worth DP; Will EJ
    Lancet; 1988 Mar; 1(8586):658. PubMed ID: 2894600
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime--a population study in 25 elderly patients.
    Urien S; Laurent N; Barre J; Druguet M; Bouvier D'yvoire M; Maire P
    Eur J Clin Pharmacol; 2004 Mar; 60(1):11-6. PubMed ID: 14767629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.